Combined captopril treatment in severe and moderately severe hypertension resistant to therapy
- PMID: 3075402
Combined captopril treatment in severe and moderately severe hypertension resistant to therapy
Abstract
Combined Captopril treatment was applied in 61 patients with severe or moderately severe hypertension in patients insufficiently or not reacting to the usual combined antihypertensive therapy (3-7 kinds of drug). The combination included diuretics, beta-blockers, alpha-blockers, vasodilators, Ca-antagonists and centrally acting agents. Diuretics were used in all cases. Average duration of treatment was 8.2 months (i.e. 2-40 months). Mean systolic pressure prior to Captopril treatment was 202.4 mm Hg (S.D. +/- 27.6), while the diastolic 122.0 mm Hg (S.D. +/- 11.3). During combined Captopril treatment the average values were 154.2 mm Hg (S.D. +/- 18.8) and 97.6 mm Hg diastolic pressures (S.D. +/- 10.7), the difference being significant (p less than 0.001). Refractory hypertension occurred in three middle-aged female patients in response to combined Captopril treatments. Captopril treatment had to be discontinued for the appearance of side-effects (severe skin symptoms) only in a single case. A minor deterioration of renal functions was observed in three patients (in one bilateral renovascular, and in two essential hypertension). Serum creatinine value and renal functions of four patients showed significant improvement as a result of combined Captopril treatment. During combined Captopril treatments (also with a diuretic) two patients had so severe hypokalaemia that they needed potassium substitution or administration of a potassium-saving diuretic.
Similar articles
-
Efficacy and safety of captopril in the treatment of severe childhood hypertension: report of the International Collaborative Study Group.Pediatrics. 1985 Jun;75(6):1091-100. Pediatrics. 1985. PMID: 3889818
-
Acute titration and chronic follow-up with captopril in hypertension. A one-year safety profile on combination therapy with captopril and a diuretic.Angiology. 1986 Dec;37(12 Pt 1):865-79. Angiology. 1986. PMID: 2880534
-
[Captopril in treatment-resistant hypertension (author's transl)].Schweiz Med Wochenschr. 1980 Dec 20;110(51):1987-91. Schweiz Med Wochenschr. 1980. PMID: 7025191 German.
-
New developments in the treatment of severe drug resistant hypertension.Cardiol J. 2011;18(6):707-11. Cardiol J. 2011. PMID: 22113765 Review.
-
Challenges in therapy of hypertension in the elderly.Am J Hypertens. 1988 Oct;1(4 Pt 2):372S-377S. doi: 10.1093/ajh/1.4.372s. Am J Hypertens. 1988. PMID: 3056447 Review.
Cited by
-
Zebrafish as an emerging model for studying complex brain disorders.Trends Pharmacol Sci. 2014 Feb;35(2):63-75. doi: 10.1016/j.tips.2013.12.002. Epub 2014 Jan 9. Trends Pharmacol Sci. 2014. PMID: 24412421 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Medical